Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunopathogenesis of hidradenitis suppurativa and response to anti–TNF-α therapy
Margaret M. Lowe, Haley B. Naik, Sean Clancy, et al.
JCI Insight (2020) Vol. 5, Iss. 19
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis
Jóhann E. Guðjónsson, Lam C. Tsoi, Feiyang Ma, et al.
JCI Insight (2020) Vol. 5, Iss. 19
Open Access | Times Cited: 144
Hidradenitis suppurativa
Robert Sabat, Afsáneh Alavi, Kerstin Wolk, et al.
The Lancet (2025)
Open Access | Times Cited: 2
Unravelling the complex pathogenesis of hidradenitis suppurativa
John W. Frew
British Journal of Dermatology (2025) Vol. 192, Iss. Supplement_1, pp. i3-i14
Open Access | Times Cited: 2
Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets
Jaehwan Kim, Jongmi Lee, Hyun Je Kim, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 5, pp. 1281-1292
Open Access | Times Cited: 83
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa
Samuel A Der Sarkissian, Schapoor Hessam, Joslyn S. Kirby, et al.
JAMA Dermatology (2022) Vol. 158, Iss. 3, pp. 300-300
Open Access | Times Cited: 48
Insights into hidradenitis suppurativa
Kelsey R. van Straalen, Errol P. Prens, Jóhann E. Guðjónsson
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 4, pp. 1150-1161
Closed Access | Times Cited: 46
Keratinocytes and immune cells in the epidermis are key drivers of inflammation in hidradenitis suppurativa providing a rationale for novel topical therapies
Stephanie L Schell, Zhaoyuan Cong, Mackenzie L. Sennett, et al.
British Journal of Dermatology (2022) Vol. 188, Iss. 3, pp. 407-419
Closed Access | Times Cited: 39
Single-cell transcriptomics suggest distinct upstream drivers of IL-17A/F in hidradenitis versus psoriasis
Jaehwan Kim, Jongmi Lee, Xuan Li, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 3, pp. 656-666
Open Access | Times Cited: 39
Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape
James G. Krueger, John W. Frew, Gregor B. E. Jemec, et al.
British Journal of Dermatology (2023) Vol. 190, Iss. 2, pp. 149-162
Open Access | Times Cited: 28
Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases
Fareed Ahmad, Majid Alam, Abdul W. Ansari, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 2, pp. 206-224
Closed Access | Times Cited: 14
The epithelial barrier theory and its associated diseases
Na Sun, İsmail Öğülür, Yasutaka Mitamura, et al.
Allergy (2024)
Open Access | Times Cited: 12
Target molecules for future hidradenitis suppurativa treatment
Christos C. Zouboulis, John W. Frew, Evangelos J. Giamarellos‐Bourboulis, et al.
Experimental Dermatology (2021) Vol. 30, Iss. S1, pp. 8-17
Open Access | Times Cited: 53
In-Depth Analysis of the Hidradenitis Suppurativa Serum Proteome Identifies Distinct Inflammatory Subtypes
Kristina Navrazhina, Sandra Garcet, Juana Gonzalez, et al.
Journal of Investigative Dermatology (2021) Vol. 141, Iss. 9, pp. 2197-2207
Open Access | Times Cited: 46
Interleukin‐17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum
Kristina Navrazhina, John W. Frew, David Grand, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 2, pp. 223-233
Open Access | Times Cited: 36
Innate immunity and microbial dysbiosis in hidradenitis suppurativa – vicious cycle of chronic inflammation
Divya Chopra, Rachel A. Arens, Watcharee Amornpairoj, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Macrophages in Skin Wounds: Functions and Therapeutic Potential
Seen Ling Sim, Snehlata Kumari, Simranpreet Kaur, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1659-1659
Open Access | Times Cited: 34
Transcriptome Meta-Analysis Confirms the Hidradenitis Suppurativa Pathogenic Triad: Upregulated Inflammation, Altered Epithelial Organization, and Dysregulated Metabolic Signaling
Ana Sofia Lima Estevão de Oliveira, Giovanna Bloise, Chiara Moltrasio, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1371-1371
Open Access | Times Cited: 28
Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativa
Kelsey R. van Straalen, Feiyang Ma, Pei‐Suen Tsou, et al.
Journal of Clinical Investigation (2023) Vol. 134, Iss. 3
Open Access | Times Cited: 21
A proof-of-concept open-label clinical trial of spleen tyrosine kinase antagonism using fostamatinib in moderate-to-severe hidradenitis suppurativa
Rebecca Jepsen, C M Edwards, Akshay Flora, et al.
Journal of the American Academy of Dermatology (2023) Vol. 89, Iss. 4, pp. 694-702
Closed Access | Times Cited: 19
Targeting the NLRP3 inflammasome reduces inflammation in hidradenitis suppurativa skin
Barry Moran, Conor M Smith, Alexandra Zaborowski, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 4, pp. 447-458
Open Access | Times Cited: 18
S2k-Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa (ICD-10-Code: L73.2)
Christos C. Zouboulis, Falk G. Bechara, Klaus Fritz, et al.
Aktuelle Dermatologie (2024) Vol. 50, Iss. 01/02, pp. 30-83
Closed Access | Times Cited: 7
Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
Isabella J. Tan, Alicia Podwójniak, Aarushi K. Parikh, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 2975-2990
Open Access | Times Cited: 7
Autoantibodies Present in Hidradenitis Suppurativa Correlate with Disease Severity and Promote the Release of Proinflammatory Cytokines in Macrophages
Carmelo Carmona‐Rivera, Liam J. O’Neil, Eduardo Patiño‐Martínez, et al.
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 3, pp. 924-935
Open Access | Times Cited: 37
The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris
Kristina Navrazhina, Sandra Garcet, John W. Frew, et al.
Journal of the American Academy of Dermatology (2021) Vol. 86, Iss. 2, pp. 322-330
Open Access | Times Cited: 35
Yin and Yang: A disrupted skin microbiome and an aberrant host immune response in hidradenitis suppurativa
Stephanie L Schell, Andreá Schneider, Amanda M. Nelson
Experimental Dermatology (2021) Vol. 30, Iss. 10, pp. 1453-1470
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top